Ekins-Daukes Suzie, Helms Peter J, Simpson Colin R, Taylor Michael W, McLay James S
Department of Medicine and Therapeutics, The University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK.
Eur J Clin Pharmacol. 2004 Jul;60(5):349-53. doi: 10.1007/s00228-004-0752-1. Epub 2004 May 14.
To investigate the extent and pattern of off-label prescribing to children in primary care throughout Scotland.
Assessment of prescribing to 167,865 children aged 0-16 years during the period November 1999 to October 2000 using data from 161 general practices using the national Scottish primary care computer system General Practice Administration System for Scotland.
One hundred and sixty one general practices in Scotland.
During the study period, at least one off-label prescription was issued to 17,715 (26.1%) children aged 0-16 years. Off-label prescribing due to lower than the recommended dose was the most common form of off-label prescribing (40-50%), with antibiotics and antihistamines making up the majority. Off-label prescribing due to higher than the recommended dose was also common (35% of all off-label prescribing), with antiasthmatics, topical corticosteroids and laxatives making up the majority. Off-label prescribing with respect to age was less common (6-16%) affecting mainly young children (less than 2 years old) and adolescents. Off-label prescribing with respect to formulation was the least common cause accounting for 5-10% of off-label prescribing.
This is the largest and most detailed study to date of paediatric off-label prescribing in primary care within the UK. Such off-label prescribing likely occurs as the result of several factors including a failure to update licensing information with currently accepted practice and confusion or unawareness of the licensing recommendations, further compounded by a lack of clinical trials data and suitable formulations for medicines commonly prescribed to young children and adolescents.
调查苏格兰全科医疗中针对儿童的超说明书用药的范围和模式。
利用苏格兰国家全科医疗计算机系统“苏格兰全科医疗管理系统”的数据,对1999年11月至2000年10月期间161家全科医疗机构中167,865名0至16岁儿童的用药情况进行评估。
苏格兰的161家全科医疗机构。
在研究期间,至少有一张超说明书处方开具给了17,715名(26.1%)0至16岁儿童。因低于推荐剂量而进行的超说明书用药是最常见的超说明书用药形式(40 - 50%),其中抗生素和抗组胺药占多数。因高于推荐剂量而进行的超说明书用药也很常见(占所有超说明书用药的35%),其中平喘药、外用糖皮质激素和泻药占多数。与年龄相关的超说明书用药较少见(6 - 16%),主要影响幼儿(2岁以下)和青少年。与剂型相关的超说明书用药是最不常见的原因,占超说明书用药的5 - 10%。
这是英国迄今为止关于全科医疗中儿科超说明书用药规模最大且最详细的研究。这种超说明书用药可能是由多种因素导致的,包括未能根据当前公认的做法更新药品许可信息、对许可建议的混淆或不了解,缺乏临床试验数据以及适合幼儿和青少年常用药物的剂型等问题进一步加剧了这种情况。